Kambiz Yazdi
Stock Analyst at Jefferies
(2.47)
# 2,344
Out of 4,896 analysts
7
Total ratings
42.86%
Success rate
20.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTX Avalo Therapeutics | Initiates: Buy | $23 | $4.88 | +371.31% | 1 | Mar 25, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $19 | $15.01 | +26.58% | 2 | Mar 11, 2025 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $15 | $10.36 | +44.79% | 1 | Aug 28, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $5 | $1.26 | +296.83% | 1 | Apr 12, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $75 → $128 | $50.58 | +153.06% | 2 | Mar 26, 2024 |
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $23
Current: $4.88
Upside: +371.31%
Arcutis Biotherapeutics
Mar 11, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $15.01
Upside: +26.58%
EyePoint Pharmaceuticals
Aug 28, 2024
Initiates: Buy
Price Target: $15
Current: $10.36
Upside: +44.79%
PMV Pharmaceuticals
Apr 12, 2024
Initiates: Buy
Price Target: $5
Current: $1.26
Upside: +296.83%
Praxis Precision Medicines
Mar 26, 2024
Maintains: Buy
Price Target: $75 → $128
Current: $50.58
Upside: +153.06%